Appeals court judges’ questions and comments suggested they may be skeptical of Trump administration changes to research ...

The Federal Trade Commission has raised concerns about Novo Nordisk’s attempt to outbid Pfizer to acquire obesity startup ...

Healthy people who suffer traumatic spinal injuries are at significantly greater risk for long-term chronic health conditions ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...

FDA's digital advisors could nudge the agency to clarify how its rules apply to medical applications of generative AI, ...

Novo Nordisk's new CEO said he was confident in the company's pipeline of obesity drugs, but that buying Metsera would allow ...

Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

Danielle Bittterman on finding vulnerabilities in LLMs to make them safer, in this edition of the AI Prognosis newsletter.

The aggravating prior authorization process includes one step that merits scrutiny and potentially regulatory action: the ...

Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D ...

CPR can be brutal and ineffective for people clearly at the end of life, but families often insist on it anyway. How should ...

What is "fake" CPR, and why do doctors sometimes do it? STAT's Alex Hogan explains in this week's episode of STATus Report.